MiR-133b regulates bladder cancer cell proliferation and apoptosis by targeting Bcl-w and Akt1

被引:55
作者
Chen, Xiao-nan [1 ]
Wang, Ke-feng [1 ]
Xu, Zhen-qun [1 ]
Li, Shi-jie [1 ]
Liu, Qiang [1 ]
Fu, Dong-hui [1 ]
Wang, Xia [1 ]
Wu, Bin [1 ]
机构
[1] China Med Univ, Shengjing Hosp, Dept Urol, Shenyang 11004, Liaoning, Peoples R China
来源
CANCER CELL INTERNATIONAL | 2014年 / 14卷
关键词
miR-133b; Bcl-w; Akt1; Bladder cancer; Proliferation; Apoptosis; MIRNA EXPRESSION; UROTHELIAL CARCINOMAS; COLORECTAL-CANCER; TUMOR SUPPRESSORS; LUNG-CANCER; MICRORNAS; DEATH; IDENTIFICATION; ACTIVATION; MUTATIONS;
D O I
10.1186/s12935-014-0070-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: MiR-133b is a muscle-specific microRNA; it has a role in the formation of cardiocytes and the expression of myocardium ion channels by regulating target genes. Many human malignant tumors demonstrate a low expression of miR-133b, as noted in colorectal, lung, esophagus and bladder cancers, but the role of miR-133b in bladder cancer is unknown. Methods: The expression of miR-133b in clinical bladder cancer specimens and adjacent normal tissues was confirmed by stem-loop RT-PCR. We also analyzed the relationship between miR-133b expression and clinicopathological factors of bladder cancer. Bcl-w and Akt1 protein expression in 41 bladder cancer specimens and adjacent normal tissues was detected by Western blot. After transfection of miR-133b mimics or inhibitor into a T24 human bladder cancer cell line, Bcl-w and Akt1 protein and mRNA expression were examined by Western blot and RT-PCR, respectively. The effect of miR-133b on T24 cell proliferation and apoptosis was measured by CCK-8 tests and flow cytometry, respectively. Results: The expression of miR-133b in bladder cancer tissues from 41 patients was significantly down-regulated (P < 0.01); low expression of miR-133b was strongly associated with high-grade bladder cancer (P < 0.01). Bcl-w and Akt1 proteins were significantly overexpressed in bladder cancer tissues versus adjacent normal tissues (P < 0.01 for both). The expression of Akt1 and Bcl-w proteins and Akt1 mRNA, in T24 cells was significantly down-regulated or up-regulated after transfection of miR-133b mimics or inhibitor, respectively; however, there was no significant difference in Bcl-w mRNA expression. Transfection of HEK-293 T cells with miR-133b significantly suppressed a luciferase-reporter containing the Bcl-w or Akt 1 3'-untranslated regions. MiR-133b mimics significantly inhibited T24 cell proliferation, as well as increased T24 cell apoptosis (P < 0.05 and P < 0.01, respectively) while the miR-133b inhibitor increased and decreased these, respectively (P < 0.05 for both). Conclusions: MiR-133b may play a very important role in the proliferation and apoptosis of T24 cells by regulating the expression of Bcl-w and Akt1.
引用
收藏
页数:11
相关论文
共 40 条
[1]   The Bcl-2 apoptotic switch in cancer development and therapy [J].
Adams, J. M. ;
Cory, S. .
ONCOGENE, 2007, 26 (09) :1324-1337
[2]   MicroRNA pathways in flies and worms: Growth, death, fat, stress, and timing [J].
Ambros, V .
CELL, 2003, 113 (06) :673-676
[3]   AKT1 mutations in bladder cancer: identification of a novel oncogenic mutation that can co-operate with E17K [J].
Askham, J. M. ;
Platt, F. ;
Chambers, P. A. ;
Snowden, H. ;
Taylor, C. F. ;
Knowles, M. A. .
ONCOGENE, 2010, 29 (01) :150-155
[4]   Bcl-w promotes gastric cancer cell invasion by inducing matrix metalloproteinase-2 expression via phosphoinositide 3-kinase, Akt, and Sp1 [J].
Bae, In Hwa ;
Park, Myung-Jin ;
Yoon, Sung Hwan ;
Kang, Sung Wook ;
Lee, Seung-Sook ;
Choi, Kyung-Mi ;
Um, Hong-Duck .
CANCER RESEARCH, 2006, 66 (10) :4991-4995
[5]   MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets [J].
Baffa, Raffaele ;
Fassan, Matteo ;
Volinia, Stefano ;
O'Hara, Brian ;
Liu, Chang-Gong ;
Palazzo, Juan P. ;
Gardiman, Marina ;
Rugge, Massimo ;
Gomella, Leonard G. ;
Croce, Carlo M. ;
Rosenberg, Anne .
JOURNAL OF PATHOLOGY, 2009, 219 (02) :214-221
[6]   Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues [J].
Bandres, E. ;
Cubedo, E. ;
Agirre, X. ;
Malumbres, R. ;
Zarate, R. ;
Ramirez, N. ;
Abajo, A. ;
Navarro, A. ;
Moreno, I. ;
Monzo, M. ;
Garcia-Foncillas, J. .
MOLECULAR CANCER, 2006, 5 (1)
[7]   MicroRNAs: Genomics, biogenesis, mechanism, and function (Reprinted from Cell, vol 116, pg 281-297, 2004) [J].
Bartel, David P. .
CELL, 2007, 131 (04) :11-29
[8]   A miRNA expression signature that separates between normal and malignant prostate tissues [J].
Carlsson, Jessica ;
Davidsson, Sabina ;
Helenius, Gisela ;
Karlsson, Mats ;
Lubovac, Zelmina ;
Andren, Ove ;
Olsson, Bjorn ;
Klinga-Levan, Karin .
CANCER CELL INTERNATIONAL, 2011, 11
[9]   Distinct MicroRNA Alterations Characterize High- and Low-Grade Bladder Cancer [J].
Catto, James W. F. ;
Miah, Saiful ;
Owen, Helen C. ;
Bryant, Helen ;
Myers, Katie ;
Dudziec, Ewa ;
Larre, Stephane ;
Milo, Marta ;
Rehman, Ishtiaq ;
Rosario, Derek J. ;
Di Martino, Erica ;
Knowles, Margaret A. ;
Meuth, Mark ;
Harris, Adrian L. ;
Hamdy, Freddie C. .
CANCER RESEARCH, 2009, 69 (21) :8472-8481
[10]   miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer [J].
Chiyomaru, T. ;
Enokida, H. ;
Tatarano, S. ;
Kawahara, K. ;
Uchida, Y. ;
Nishiyama, K. ;
Fujimura, L. ;
Kikkawa, N. ;
Seki, N. ;
Nakagawa, M. .
BRITISH JOURNAL OF CANCER, 2010, 102 (05) :883-891